DOCK8 and autoimmune disease: Taken together, these data show that DOCK8 can regulate the levels of glycolysis and oxidative phosphorylation by stabilizing the mTOR/HIF‐1α signaling pathway, thereby inhibiting the abnormal differentiation of Th17 cell and autoimmune disease development.